Bayer completes acquisition of Dihon Pharmaceutical Group Co., Ltd.
Bayer has completed the acquisition of 100 percent of the shares of Dihon Pharmaceutical Group Co., Ltd., Kunming, Yunnan, China, a privately held pharmaceutical company specializing primarily in over-the-counter (OTC) dermatology products and herbal traditional Chinese medicine (TCM) produ ... more
Bayer operationally strong – strategic focus on Life Science businesses
The Bayer Group continued its successful business development. “The strong upward trend in the Life Science businesses – HealthCare and CropScience – persisted in the third quarter. We saw robust sales growth for our recently launched pharmaceutical products and in our CropScience business ... more
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for USD 14.2 billion
Bayer has completed the acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co., Inc., Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals. "This acquisition is a milestone for Bayer and ... more